Cipla Ltd.

NSE: CIPLA | BSE: 500087 | ISIN: INE059A01026 | Industry: Pharmaceuticals
| Mid-range Performer
1574.6000 13.80 (0.88%)
NSE Sep 12, 2025 15:51 PM
Volume: 785.5K
 

logo
Cipla Ltd.
28 Aug 2018
1574.60
0.88%
Geojit BNP Paribas
Revenue growth led by improved India and SA performance Cipla reported 12% YoY growth in revenue in Q1FY19 on the back of continued strong growth across India (up 22% YoY), South Africa (up 23% YoY) and API business (up 54% YoY). The company highlighted that the growth in India business in Q2FY19 should be lower as compared to corresponding quarter last year due to high base on account of GST led re-stocking. The company's South Africa business delivered yet another strong quarter with a robust 23% YoY increase in revenue (15% in dollar terms), outperforming the market (7% in dollar terms) led by strong momentum in Sereflo Synchrobreathe which grew at 45% YoY. Going ahead, the company remains optimistic about the growth...
Deven Choksey released a Hold report for Cipla Ltd. with a price target of 1570.0 on 08 Sep, 2025.
More from Cipla Ltd.
Recommended